- Trials with a EudraCT protocol (83)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
83 result(s) found for: Humoral immunity.
Displaying page 1 of 5.
| EudraCT Number: 2011-002928-41 | Sponsor Protocol Number: Immunity_TBE | Start Date*: 2013-01-14 |
| Sponsor Name:Med. Uni. Wien, Klinik für Innere I | ||
| Full Title: Characterization of humoral and cellular immunity for tick-borne encephalitis (TBE) vaccination in allogeneic blood and marrow graft recipients: a pilot study | ||
| Medical condition: Characterization of humoral and cellular immunity for tick-borne encephalitis (TBE) vaccination in allogeneic blood and marrow graft recipients: a pilot study Study group consists of patients 11... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2019-004541-33 | Sponsor Protocol Number: immvzmpr1 | Start Date*: Information not available in EudraCT |
| Sponsor Name:Västra Götalandsregionen | ||
| Full Title: A clinical study to examine cellular and humoral immunity against measles and chickenpox in children and adolescents 0-18 years in childhood cancer. | ||
| Medical condition: This study will be conducted as a longitudinal study. Former studies have shown that immunity is affected after treatment against childhood cancer. We want to investigate humoral and cell-mediated ... | ||
| Disease: | ||
| Population Age: Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: SE (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-002088-23 | Sponsor Protocol Number: DemiVac2021 | Start Date*: 2021-05-05 |
| Sponsor Name:Sciensano | ||
| Full Title: Covid-19: Safety and Immunogenicity of a Reduced Dose of the BioNTech/Pfizer BNT162b2 Vaccine in a Healthy Population (REDU-VAC) | ||
| Medical condition: Healthy persons from age 18 till age 56 | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-017138-36 | Sponsor Protocol Number: 30493 | Start Date*: 2009-11-11 |
| Sponsor Name:St Elisabeth Hospital | ||
| Full Title: Influenza H1N1 Immunogenicity study | ||
| Medical condition: No medical condition. Our aim is to study the immunogenicity against influenza virus H1N1(2009) before and after vaccination | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2010-020450-33 | Sponsor Protocol Number: IX-senesc2.0 | Start Date*: 2010-06-23 | |||||||||||
| Sponsor Name:Institute of Specific Prophylaxis and Tropical Medicine | |||||||||||||
| Full Title: Characterization of cellular and humoral immunity in the elderly upon vaccination with the purified inactivated Japanese Encephalitis Vaccine IXIARO® | |||||||||||||
| Medical condition: The aim of this project is to investigate humoral and cellular immune responses before and after immunisation with the Japanese encephalitis vaccine IXIARO in subjects above 65 years of age in comp... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: AT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2008-005800-24 | Sponsor Protocol Number: version1.0 | Start Date*: 2008-10-22 | |||||||||||
| Sponsor Name:Medizinische Universität Wien, Institut für Spezifische Prophylaxe und Tropenmedizin | |||||||||||||
| Full Title: Characterisation of humoral and cellular immunity of low- and high-responder after TBE vaccination | |||||||||||||
| Medical condition: The aim of this project is to investigate the humoral and cellular immune responses of low-responders after TBE vaccination in order to find parameters regarding immunoregulation against TBE. It is... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: AT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2021-004891-33 | Sponsor Protocol Number: T33/2021 | Start Date*: 2022-04-13 |
| Sponsor Name:Turku University Hospital | ||
| Full Title: COVID-19 vaccine induced immune response in patients with primary antibody deficiency | ||
| Medical condition: COVID-19 | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FI (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-004419-14 | Sponsor Protocol Number: T125/2020 | Start Date*: 2021-10-18 |
| Sponsor Name:Turku University Hospital | ||
| Full Title: COVID-19 infections in hospital personnel | ||
| Medical condition: COVID-19 | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FI (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-001453-74 | Sponsor Protocol Number: Version01.1. | Start Date*: 2012-05-15 |
| Sponsor Name:Institute of Specific Prophylaxis and Tropical Medicine | ||
| Full Title: Comparison of vaccination routes: subcutaneus versus intramuscular application of FSME-Immun® | ||
| Medical condition: TBE vaccine (FSME-Immun®) is registered for intra-muscular application. Due to medical reasons (e.g. anticoagulant therapy, adipositas) intra-muscular application is not always possible. The aim o... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-005672-34 | Sponsor Protocol Number: FSME_only_1.1 | Start Date*: 2013-03-05 |
| Sponsor Name:Institut für Spezifische Prophylaxe | ||
| Full Title: Application of FSME-Immun® in allergic patients | ||
| Medical condition: Allergic patients have generally an altered immune-responsiveness (Th2 bias), and allergic individuals undergoing de-sensitization display an increased production of immune supressive cytokines. We... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2020-003466-39 | Sponsor Protocol Number: Protocol_MAMA_studie_22/05/2018 | Start Date*: Information not available in EudraCT |
| Sponsor Name:University of Antwerp | ||
| Full Title: Pertussis immunization during pregnancy: assessment of the role of maternal antibodies on immune responses in term and preterm infants (the MAMA study) | ||
| Medical condition: The effect of pertussis vaccination during pregnancy on the immune response after infant and childhood vaccinations in term and preterm infants. | ||
| Disease: | ||
| Population Age: In utero, Preterm newborn infants, Newborns, Infants and toddlers, Children, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-002103-15 | Sponsor Protocol Number: VAC-259 | Start Date*: 2011-09-07 |
| Sponsor Name:RIVM | ||
| Full Title: Development of humoral and cellular immune response in infants after pneumococcal conjugate vaccinations with Synflorix® or Prevenar-13® | ||
| Medical condition: Immunity and immune memory after pneumococcal vaccination against S. pneumoniae serotypes present in either Synflorix or Prevenar-13 | ||
| Disease: | ||
| Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2021-004573-32 | Sponsor Protocol Number: 21-05 | Start Date*: 2021-10-05 |
| Sponsor Name:Centre Hospitalier Annecy Genevois | ||
| Full Title: Effect of High-Dose Quadrivalent Influenza Vaccine (Efluelda®) versus Standard-Dose (QIV-SD), in subjects 65 years of age and older on innate immunity, including gene expression. | ||
| Medical condition: Healthy volunteers (influenza vaccination) | ||
| Disease: | ||
| Population Age: Elderly | Gender: Male, Female | |
| Trial protocol: FR (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-003071-20 | Sponsor Protocol Number: C060401 | Start Date*: 2005-09-20 |
| Sponsor Name:FIT Biotech Oyj Plc | ||
| Full Title: Immunogenicity and therapeutic effects of GTU-MultiHIV B clade DNA vaccine. A randomized, controlled, phase II clinical trial in treatment-naive HIV-positive subjects | ||
| Medical condition: Treatment naive HIV infected individuals | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: FI (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-001228-32 | Sponsor Protocol Number: COV002 | Start Date*: 2020-05-04 | |||||||||||
| Sponsor Name:CTRG | |||||||||||||
| Full Title: A phase 2/3 study to determine the efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19 | |||||||||||||
| Medical condition: SARS-CoV-2 | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2017-004610-26 | Sponsor Protocol Number: OVG2017/10 | Start Date*: 2018-11-28 | |||||||||||
| Sponsor Name:Clinical Trials and Research Governance (CTRG), University of Oxford | |||||||||||||
| Full Title: Evaluating the Long Term Immunogenicity of adenoviral and MVA vectored Ebola vaccine schedules and response to late boosting with AD26.ZEBOV vaccine: an open-label clinical trial | |||||||||||||
| Medical condition: Ebola Virus Disease | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2014-000570-19 | Sponsor Protocol Number: TBE_obesity_1.1 | Start Date*: 2014-07-11 |
| Sponsor Name:Institute of Specific Prophylaxis and Tropical Medicine | ||
| Full Title: Applikation of FSME-IMMUN® in obese persons | ||
| Medical condition: Studies have shown that obesity has a direct effect on the immune system and leads to immunosuppression, which leads to a susceptibility to infection. The aim of this study is to clarify if a modif... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: AT (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-006832-24 | Sponsor Protocol Number: Z-2021005 | Start Date*: 2022-01-21 |
| Sponsor Name:Ziekenhuis Oost-Limburg A.V. | ||
| Full Title: Heterogeneity, durability and efficacy of the humoral immune response against SARS-CoV-2 (Covid-19) after hospital-wide vaccination | ||
| Medical condition: efficiency and durability of the humoral immune response after vaccination against SARS-CoV-2 | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-000291-11 | Sponsor Protocol Number: IMRES | Start Date*: 2021-05-30 | |||||||||||
| Sponsor Name:Medical University of Vienna | |||||||||||||
| Full Title: Characterization of immune responsiveness after SARS-CoV-2 Vaccination in patients with Immunodeficiency or immunosuppressive therapy (COVID-19) | |||||||||||||
| Medical condition: Vaccination against SARS-CoV-2 in immunocompromised patients | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: AT (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2021-001512-28 | Sponsor Protocol Number: COVIM | Start Date*: 2021-05-11 | |||||||||||
| Sponsor Name:Charité - Universitätsmedizin Berlin | |||||||||||||
| Full Title: Immunogenicity of COVID-19 vaccines in medical staff and special risk populations | |||||||||||||
| Medical condition: SARS-CoV-2 immunogenicity | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
